Filing Details
- Accession Number:
- 0001104659-19-032916
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-30 21:26:25
- Reporting Period:
- 2019-05-28
- Accepted Time:
- 2019-05-30 21:26:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1761612 | Bicycle Therapeutics Plc | BCYC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1776856 | Michael Anstey | C/O Bicycle Therapeutics Plc B900, Babraham Research Campus Cambridge X0 CB22 3AT | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2019-05-28 | 1,081,823 | $0.00 | 1,081,823 | No | 4 | C | Indirect | By Cambridge Innovation Capital (Jersey) Limited |
| Ordinary Shares | Acquisiton | 2019-05-28 | 125,587 | $0.00 | 1,207,410 | No | 4 | X | Indirect | By Cambridge Innovation Capital (Jersey) Limited |
| Ordinary Shares | Acquisiton | 2019-05-28 | 229,741 | $0.00 | 1,437,151 | No | 4 | C | Indirect | By Cambridge Innovation Capital (Jersey) Limited |
| Ordinary Shares | Acquisiton | 2019-05-28 | 314,286 | $14.00 | 1,751,437 | No | 4 | P | Indirect | By Cambridge Innovation Capital (Jersey) Limited |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | By Cambridge Innovation Capital (Jersey) Limited |
| No | 4 | X | Indirect | By Cambridge Innovation Capital (Jersey) Limited |
| No | 4 | C | Indirect | By Cambridge Innovation Capital (Jersey) Limited |
| No | 4 | P | Indirect | By Cambridge Innovation Capital (Jersey) Limited |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Series B1 Preferred Shares | Acquisiton | 2019-05-28 | 1,081,823 | $0.00 | 1,081,823 | $0.00 |
| Ordinary Shares | Series B1 Preferred Shares Warrants | Acquisiton | 2019-05-28 | 125,587 | $0.00 | 125,587 | $0.00 |
| Ordinary Shares | Series B2 Preferred Shares | Acquisiton | 2019-05-28 | 229,741 | $0.00 | 229,741 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | X | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date.
- The shares are held by Cambridge Innovation Capital (Jersey) Limited. The Reporting Person is a member of our Board of Directors and an investment director at Cambridge Innovation Capital plc.
- Upon conversion of all of the Series B1 Preferred Shares into Ordinary Shares in connection with the Issuer's initial public offering, the Warrants became exercisable for Ordinary Shares. The Warrants had an exercise price of a nominal value per share and were exercised immediately prior to completion of the Issuer's initial public offering.
Billionaire Hedge Funds
